Breaking News, Collaborations & Alliances

Batavia Biosciences and KU Leuven Join Forces

Will accelerate the development of a highly promising Covid-19 vaccine candidate.

By: Contract Pharma

Contract Pharma Staff

KU Leuven, a research institution and one of the top 50 universities in the world, and Batavia Biosciences, a contract development and manufacturing organization focused on delivering sustainable manufacturing solutions in the field of vaccines and oncology, have partnered to develop a vector based COVID-19 vaccine candidate.   The virology team at the KU Leuven Rega Institute for Medical Research, headed by Dr. Johan Neyts, has developed a SARS-CoV-2 vaccine candidate consisting of an attenuate...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters